K200597 is an FDA 510(k) clearance for the Straumann BLX Gold Abutments. This device is classified as a Abutment, Implant, Dental, Endosseous (Class II - Special Controls, product code NHA).
Submitted by Straumann USA, LLC (On Behalf of Institut Straumann Ag) (Andover, US). The FDA issued a Cleared decision on August 19, 2020, 163 days after receiving the submission on March 9, 2020.
This device falls under the Dental FDA review panel. Regulated under 21 CFR 872.3630. To Be Used In Conjunction With An Endosseous Dental Implant Fixture To Aid In Prosthetic Rehabilitation..